A VP1 mutation acquired during an enterovirus 71 disseminated infection confers heparan sulfate binding ability and modulates ex vivo tropism - PubMed
- ️Mon Jan 01 2018
A VP1 mutation acquired during an enterovirus 71 disseminated infection confers heparan sulfate binding ability and modulates ex vivo tropism
Eirini D Tseligka et al. PLoS Pathog. 2018.
Abstract
Enterovirus 71 (EV71) causes hand, foot and mouth disease, a mild and self-limited illness that is sometimes associated with severe neurological complications. EV71 neurotropic determinants remain ill-defined to date. We previously identified a mutation in the VP1 capsid protein (L97R) that was acquired over the course of a disseminated infection in an immunocompromised host. The mutation was absent in the respiratory tract but was present in the gut (as a mixed population) and in blood and cerebrospinal fluid (as a dominant species). In this study, we demonstrated that this mutation does not alter the dependence of EV71 on the human scavenger receptor class B2 (SCARB2), while it enables the virus to bind to the heparan sulfate (HS) attachment receptor and modifies viral tropism in cell lines and in respiratory, intestinal and neural tissues. Variants with VP197L or VP197R were able to replicate to high levels in intestinal and neural tissues and, to a lesser extent, in respiratory tissues, but their preferred entry site (from the luminal or basal tissue side) differed in respiratory and intestinal tissues and correlated with HS expression levels. These data account for the viral populations sequenced from the patient's respiratory and intestinal samples and suggest that improved dissemination, resulting from an acquired ability to bind HS, rather than specific neurotropism determinants, enabled the virus to reach and infect the central nervous system. Finally, we showed that iota-carrageenan, a highly sulfated polysaccharide, efficiently blocks the replication of HS-dependent variants in cells and 2D neural cultures. Overall, the results of this study emphasize the importance of HS binding in EV71 pathogenesis and open new avenues for the development of antiviral molecules that may prevent this virus's dissemination.
Conflict of interest statement
SH and SC are employees of Epithelix Sàrl. There is no other relevant information linked to this affiliation that presents any conflict of interest. Moreover, we confirm that this affiliation does not alter our adherence to all PLOS Pathogens policies on sharing data and materials.
Figures

The mean (N = 2) viral titers (±SEM) expressed as log TCID50/ml (median tissue culture infective dose) obtained 4 dpi are indicated. *P<0.05.

A) Mean (N = 2) viral titers (±SEM) expressed as log TCID50/ml (median tissue culture infective dose) obtained 5 dpi in cells expressing (control) or not (ΔSCARB2) SCARB2. Wells with less than 50 infected cells were considered as negative. B) Western blot showing SCARB2 expression in ΔSCARB2 cells and control cells. ****P<0.0001, **P<0.01, *P<0.05.

(A). Binding of EV71-VP197R167G (left panel) and EV71-VP197L167E (right panel) in the presence or absence of HS. Binding (B) and replication (C) of a viral stock composed of equivalent amounts of EV71-VP197R167G and EV71-VP197L167E in different cell lines and under conditions preventing attachment to HS. Viral loads were measured by RT-qPCR (real-time quantitative reverse transcription PCR) in whole cell extracts for binding assay and both cell extracts and supernatants for replication assay, and expressed as the mean (±SEM, N≥2) relative to the EV71-VP197R167G load in non-treated RD cells (100%). (D). Quantification of HS-expressing (positive) cells was achieved through an analysis using MetaMorph software (left panel) based on the immunofluorescence labeling (right panel) of HS attachment receptors at the surface of Vero, RD, SH-SY5Y cells and Caco-2 cells. More than 500 cells were included in the analysis. Scale bar = 20 μm. (E) Binding of EV71-VP197R/L167G/E to heparin sepharose beads. Viral population present in the input, flow-through and elute population was characterized by sequencing. ****P<0.0001, ***P<0.001, **P<0.01, *P<0.05. For B, C and E, the frequency plot [
http://weblogo.berkeley.edu/] of codons encoding VP1 aa 97, 98 and 167 are shown and are representative of biological replicates (N≥2). Arginine (R) at position 97 is encoded by CGC, Leucine (L) by CTC; Glutamate (E) at position 98 is encoded by GAA, Lysine (K) by AAA; Glycine (G) at position 167 is encoded by GGG, Glutamate (E) by CTC.

Replication of EV71-VP197R167G, EV71-VP197L167E and EV71-VP197R/L167G/E in reconstituted airway epithelia developed from the upper (A) and lower (B) respiratory tract and HS/SCARB2 expression in the same tissues (C -D). (A-B) Viral loads were measured by RT-qPCR 5 dpi in the apically collected washes of the apically or basally inoculated tissues and are expressed as the mean ±SEM (N≥2). ***P<0.001, **P<0.01, *P<0.05. Frequency plots are shown on the right (see Fig 3 for details) (C-D) Tissue sections were colored with hematoxylin and eosin (upper panel) or labeled by immunofluorescence. SCARB2 is stained in green, HS in red and cell nuclei in blue. Scale bar = 20 μm.

Replication of EV71-VP197R167G, EV71-VP197L167E and EV71-VP197R/L167G/E in reconstituted small intestine tissues (A) and HS/SCARB2 expression in the same tissues (B and C). (A) Viral loads were measured by RT-qPCR 5 dpi in the apically collected washes of the apically or basally inoculated tissues and are expressed as the mean (±SEM) N = 2. **P<0.01, *P<0.05. The frequency plots are shown on the right (see Fig 3 for details) (B) Tissue sections were colored with hematoxylin and eosin (upper panel) or labeled by immunofluorescence. SCARB2 is stained in green, HS in red and cell nuclei in blue. Scale bar = 20 μm. (C) Quantification of HS expression at the apical and basal surface of intestinal tissues was achieved through an analysis using MetaMorph software based on the immunofluorescence labeling of HS attachment receptor in sectioned tissues.

Replication of EV71-VP197R167G, EV71-VP197L167E and EV71-VP197R/L167G/E in 2D (A) and 3D (B) neural tissues and HS/SCARB2 expression in the same 2D tissues (C). (A-B) Viral load was measured by RT-qPCR and expressed as the mean (±SEM). (N = 2). ****P<0.0001, ++P<0.01 or #P<0.05. (+relative to EV71-VP197L167E and # relative to EV71-VP197R/L167G/E at the same time point). The frequency plots are shown on the right (see Fig 3 for details) (C) 2D neural cultures were labeled by immunofluorescence. SCARB2 is stained in green, HS in red and cell nuclei in blue. Scale bar = 20 μm.

Viral infectivity of EV71-VP197R167G and EV71-VP197L167E in Vero cells (A) and of EV71-VP197R167G, EV71-VP197L167E and EV71-VP197L/R167E/G in neural cells (B) in the presence of increasing doses of ı-carrageenan. The percent of infection was measured by an immunocytochemistry assay in Vero cells (A) and by RT-qPCR on cell lysate 1 dpi in neural cells (B) and expressed as the mean (±SEM) compared to non-treated viruses. (N = 2). **P<0.005. The frequency plots are shown on the right (see Fig 3 for details).
Similar articles
-
Kobayashi K, Sudaka Y, Takashino A, Imura A, Fujii K, Koike S. Kobayashi K, et al. J Virol. 2018 Jul 17;92(15):e00681-18. doi: 10.1128/JVI.00681-18. Print 2018 Aug 1. J Virol. 2018. PMID: 29848584 Free PMC article.
-
Ke X, Zhang Y, Liu Y, Miao Y, Zheng C, Luo D, Sun J, Hu Q, Xu Y, Wang H, Zheng Z. Ke X, et al. Viruses. 2020 Aug 13;12(8):883. doi: 10.3390/v12080883. Viruses. 2020. PMID: 32823486 Free PMC article.
-
SLC35B2 Acts in a Dual Role in the Host Sulfation Required for EV71 Infection.
Guo D, Yu X, Wang D, Li Z, Zhou Y, Xu G, Yuan B, Qin Y, Chen M. Guo D, et al. J Virol. 2022 May 11;96(9):e0204221. doi: 10.1128/jvi.02042-21. Epub 2022 Apr 14. J Virol. 2022. PMID: 35420441 Free PMC article.
-
Cellular receptors for enterovirus A71.
Kobayashi K, Koike S. Kobayashi K, et al. J Biomed Sci. 2020 Jan 10;27(1):23. doi: 10.1186/s12929-020-0615-9. J Biomed Sci. 2020. PMID: 31924205 Free PMC article. Review.
-
Cell and tissue tropism of enterovirus 71 and other enteroviruses infections.
Lin JY, Shih SR. Lin JY, et al. J Biomed Sci. 2014 Mar 7;21(1):18. doi: 10.1186/1423-0127-21-18. J Biomed Sci. 2014. PMID: 24602216 Free PMC article. Review.
Cited by
-
Sridhar A, Depla JA, Mulder LA, Karelehto E, Brouwer L, Kruiswijk L, Vieira de Sá R, Meijer A, Evers MM, van Kuppeveld FJM, Pajkrt D, Wolthers KC. Sridhar A, et al. Microbiol Spectr. 2022 Oct 26;10(5):e0169422. doi: 10.1128/spectrum.01694-22. Epub 2022 Sep 26. Microbiol Spectr. 2022. PMID: 36154279 Free PMC article.
-
Grizer CS, Messacar K, Mattapallil JJ. Grizer CS, et al. Front Virol. 2024;4:1328457. doi: 10.3389/fviro.2024.1328457. Epub 2024 Feb 14. Front Virol. 2024. PMID: 39246649 Free PMC article.
-
Glycocalyx as Possible Limiting Factor in COVID-19.
Wadowski PP, Jilma B, Kopp CW, Ertl S, Gremmel T, Koppensteiner R. Wadowski PP, et al. Front Immunol. 2021 Feb 22;12:607306. doi: 10.3389/fimmu.2021.607306. eCollection 2021. Front Immunol. 2021. PMID: 33692785 Free PMC article. Review. No abstract available.
-
Tseligka ED, Conzelmann S, Cambet Y, Schaer T, Negro F, Clément S. Tseligka ED, et al. JHEP Rep. 2022 Dec 17;5(3):100652. doi: 10.1016/j.jhepr.2022.100652. eCollection 2023 Mar. JHEP Rep. 2022. PMID: 36704052 Free PMC article.
-
Tee HK, Tan CW, Yogarajah T, Lee MHP, Chai HJ, Hanapi NA, Yusof SR, Ong KC, Lee VS, Sam IC, Chan YF. Tee HK, et al. PLoS Pathog. 2019 Nov 15;15(11):e1007863. doi: 10.1371/journal.ppat.1007863. eCollection 2019 Nov. PLoS Pathog. 2019. PMID: 31730673 Free PMC article.
References
-
- Brown BA, Pallansch MA. Complete nucleotide sequence of enterovirus 71 is distinct from poliovirus. Virus Res. 1995;39(2–3):195–205. . - PubMed
-
- Melnick JL. Enterovirus type 71 infections: a varied clinical pattern sometimes mimicking paralytic poliomyelitis. Rev Infect Dis. 1984;6 Suppl 2:S387–90. . - PubMed
-
- Chan LG, Parashar UD, Lye MS, Ong FG, Zaki SR, Alexander JP, et al. Deaths of children during an outbreak of hand, foot, and mouth disease in sarawak, malaysia: clinical and pathological characteristics of the disease. For the Outbreak Study Group. Clin Infect Dis. 2000;31(3):678–83. 10.1086/314032 . - DOI - PubMed
Publication types
MeSH terms
Substances
Grants and funding
This work is supported by the Swiss National Science Foundation (grant # 310030_166218 to CT) and the Leenaards Foundation (grant 4390 to CT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous